NCT04678895View on ClinicalTrials.gov

Low-Dose Naltrexone for the Treatment of Painful Diabetic Neuropathy

PHASE2RecruitingINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

December 22, 2020

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Painful Diabetic Neuropathy
Interventions
DRUG

Naltrexone

Capsule with doses of 1.5mg, 3mg, and 4.5 mg to allow for drug titration. Capsules of different dosages will be indistinguishable to allow for maintenance of blinding.

DRUG

Placebo

Naltrexone matched placebo capsule.

Trial Locations (1)

03766

RECRUITING

Dartmouth-Hitchcock Medical Center, Lebanon

All Listed Sponsors
lead

Dartmouth-Hitchcock Medical Center

OTHER